Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Research
Bio/Technology  11, 187 - 193 (1993)
doi:10.1038/nbt0293-187

A Thioredoxin Gene Fusion Expression System That Circumvents Inclusion Body Formation in the E. coli Cytoplasm

Edward R. LaVallie1, Elizabeth A. DiBlasio1, Sharlotte Kovacic1, Kathleen L. Grant1, Paul F. Schendel1 & John M. McCoy1, *

  1Genetics Institute, 87 Cambridge Park Drive, Cambridge, MA 02140.

  *Corresponding author.

We have developed a versatile Escherichia coli expression system based on the use of E. coli thioredoxin (trxA) as a gene fusion partner. The broad utility of the system is illustrated by the production of a variety of mammalian cytokines and growth factors as thioredoxin fusion proteins. Although many of these cytokines previously have been produced in E. coli as insoluble aggregates or "inclusion bodies", we show here that as thioredoxin fusions they can be made in soluble forms that are biologically active. In general we find that linkage to thioredoxin dramatically increases the solubility of heterologous proteins synthesized in the E. coli cytoplasm, and that thioredoxin fusion proteins usually accumulate to high levels. Two additional properties of E. coli thioredoxin, its ability to be specifically released from the E. coli cytoplasm by osmotic shock or freeze/thaw treatments and its intrinsic thermal stability, are retained by some fusions and provide convenient purification steps. We also find that the active-site loop of E. coli thioredoxin can be used as a general site for small peptide insertions, allowing for the high level production of soluble peptides in the E. coli cytoplasm.

REFERENCES
  1. Stormo, G.D., Schneider, T.D. and Gold, L. 1982. Characterization of translation initiation sites in E. coli. Nucl. Acids Res. 10: 2971−2996. | PubMed  | ISI | ChemPort |
  2. Gottesman, S. 1989. Genetics of proteolysis in Escherichia coli. Annu. Rev. Genet. 23: 163−198. | Article | PubMed  | ISI | ChemPort |
  3. Schein, C.H. 1989. Production of soluble recombinant proteins in bacteria. Bio/Technology 7: 1141−1149. | ISI | ChemPort |
  4. Mitraki, A. and King, J. 1989. Protein folding intermediates and inclusion body formation. Bio/Technology 7: 690−697. | ISI | ChemPort |
  5. Carter, P., Kelley, R.F., Rodrigues, M.L., Snedecor, B., Covarrubias, M., Velligan, M.D., Wong, W.L.T., Rowland, A.M., Kotts, C.E., Carver, M.E., Yang, M., Bourell, J.H., Shepard, H.M. and Henner, D. 1992. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio/Technology 10: 163−167. | PubMed  | ISI | ChemPort |
  6. Stader, J.A. and Silhavy, T.J. 1990. Engineering Escherichia coli to secrete heterologous gene products. Methods in Enzymol. 165: 166−187.
  7. Georgiou, G., Telford, J.N., Shuler, M.L. and Wilson, D.B. 1986. Localization of inclusion bodies in Escherichia coli overproducing beta-lactamase or alkaline phosphatase. Appl. Environ. Microbiol. 52: 1157−1161. | PubMed  | ISI | ChemPort |
  8. Bowden, G.A. and Giorgiou, G. 1990. Folding and aggregation of beta-lactamase in the periplasmic space of Esherichia coli. J. Biol. Chem. 265: 16760−16766. | PubMed  | ISI | ChemPort |
  9. Ruther, U. and Muller-Hill, B. 1983. Easy identification of cDNA clones. EMBO J. 2: 1791−1794. | PubMed  | ISI | ChemPort |
  10. Yansura, D.G. 1990. Expression as trpE fusion. Methods in Enzymol. 165: 161−166.
  11. Nilsson, B., Abrahmsen, L. and Uhlen, M. 1985. Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EMBO J. 4: 1075−1080. | PubMed  | ISI | ChemPort |
  12. Smith, D.B. and Johnson, K.S. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67: 31−40. | Article | PubMed  | ISI | ChemPort |
  13. Maina, C.V., Riggs, P.D., Grandea, A.G., Slatko, B.E., Moran, L.S., Tagliamonte, J.A., McReynolds, L.A. and di Guan, C. 1988. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene 74: 365−373. | Article | PubMed  | ISI | ChemPort |
  14. Holmgren, A. 1985. Thioredoxin. Ann. Rev. Biochem. 54: 237−271. | Article | PubMed  | ISI | ChemPort |
  15. Lunn, C.A., Kathju, S., Wallace, B.J., Kushner, S.R. and Pigiet, V. 1984. Amplification and purification of plasmid-encoded thioredoxin from Escherichia coli K12. J. Biol. Chem. 259: 10469−10474. | PubMed  | ChemPort |
  16. Katti, S.K., LeMaster, D.M. and Eklund, H. 1990. Crystal structure of thioredoxin from Escherichia coli at 1.68 angstroms resolution. J. Mol. Biol. 212: 167−184. | PubMed  | ISI | ChemPort |
  17. Bayer, M.E. 1968. Areas of adhesion between wall and membrane of Escherichia coli. J. Gen. Microbiol. 53: 395−404. | PubMed  | ISI | ChemPort |
  18. Lunn, C.A. and Pigiet, V.P. 1982. Localization of thioredoxin from Escherichia coli in an cosmotically sensitive compartment. J. Biol. Chem. 257: 11424−11430. | PubMed  | ChemPort |
  19. Tsuji, T., Nakagawa, R., Sugimoto, N. and Fukuhara, K.-I. 1987. Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding. Biochemistry 26: 3129−3134. | PubMed  | ISI | ChemPort |
  20. Donahue, R.E., Seehra, J., Metzger, M., Lefebvre, D., Rock, B., Carbone, S., Nathan, D.G., Garnick, M., Sehgal, P.K., Laston, D., LaVallie, E., McCoy, J., Schendel, P., Norton, C., Turner, K., Yang, Y.-C. and Clark, S.C. 1988. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241: 1820−1823. | PubMed  | ISI | ChemPort |
  21. van Kimmenade, A., Bond, M.W., Schumacher, J.H., Laquoi, C. and Kastelein, R. A. 1988. Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli. Eur. J. Biochem. 173: 109−114. | PubMed  | ChemPort |
  22. Arcone, R., Pucci, P., Zapacosta, F., Fontaine, V., Malorni, A., Marino, G. and Ciliberto, G. 1991. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur. J. Biochem. 198: 541−547. | PubMed  | ISI | ChemPort |
  23. Martin, F.H., Suggs, S.V., Langley, K.E., Lu, H.S. et al. 1990. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63: 203−211. | Article | PubMed  | ISI | ChemPort |
  24. Halenbeck, R., Kawasaki, E., Wrin, J. and Koths, K. 1989. Renaturation and purification of biologically active recombinant human macrophage colony-stimulating factor expressed in E. coli. Bio/Technology 7: 710−715. | ISI | ChemPort |
  25. Hansson, H.-A., Holmgren, A., Rozell, B. and Stemme, S. 1986. Localization of thioredoxin, thioredoxin reductase and ribonucleotide reductase in cells: immunohistochemical aspects, p. 177−187. In: Thioredoxin and Glutaredoxin Systems: Structure and Function. Holmgren, A., Branden, C.-I., Jornvall, H., and Sjoberg, B.-M.(Eds.). Raven Press, New York.
  26. Maroux, S., Baratti, J. and Desnuelle, P. 1971. Purification and specificity of porcine enterokinase. J. Biol. Chem. 246: 5031−5039. | PubMed  | ISI | ChemPort |
  27. Paul, S.R., Bennett, F., Calvetti, J.A., Kelleher, K., Wood, C.R., O'Hara, R.M., Leary, A.C., Sibley, B., Clark, S.C., Williams, D.A. and Yang, Y.-C. 1990. Molecular cloning of a cDNA encoding interleukin II, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87: 7512−7516. | PubMed  | ChemPort |
  28. Scott, J.K. and Smith, G.P. 1990. Searching for peptide ligands with an epitope library. Science 249: 386−390. | PubMed  | ISI | ChemPort |
  29. Edman, J.C., Ellis, L., Blacher, R.W., Roth, R.A. and Rutter, W.J. 1985. Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 317: 267−270. | PubMed  | ISI | ChemPort |
  30. Bennett, C.F., Balcarek, J.M., Varrichio, A. and Crooke, S.T. 1988. Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature 334: 268−270. | Article | PubMed  | ISI | ChemPort |
  31. Mazzarella, R.A., Srinivasan, M., Haugejorden, S.M. and Green, M. 1990. ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J. Biol. Chem. 265: 1094−1101. | PubMed  | ISI | ChemPort |
  32. McCoy, J.M. 1992. Heat-shock proteins and their potential uses for pharmaceutical protein production in microorganisms. In: Stability of Protein Pharmaceuticals, Part B. Ahern, T. and Manning, M. (Eds.) Plenum Press, New York.
  33. Wetzel, R., Perry, L.J., Baase, W.A. and Becktel, W.J. 1988. Disulfide bonds and thermal stability in T4 lysozyme. Proc. Natl. Acad. Sci. USA 85: 401−405. | PubMed  | ChemPort |
  34. Schein, C.H. and Noteborn, M.H.M. 1988. Formation of soluble recombinant proteins in Escherichia coli is favored by lower growth temperature. Bio/Technology 6: 291−294. | ISI | ChemPort |
  35. Joseph-Liauzum, E., Leplatois, P., Legoux, R., Guerverno, V., Marchese, E. and Ferrara, P. 1990. Human recombinant interleukin-1beta isolated from Escherichia coli by simple osmotic shock. Gene 86: 291−295. | Article | PubMed  |
  36. Rosenwasser, T.A., Hogquist, K.A., Nothwehr, S.F., Bradford-Goldberg, S., Olins, P.O., Chaplin, D.D. and Gordon, J.I. 1990. Compartmentalization of mammalian proteins produced in Escherichia coli. J. Biol. Chem. 265: 13066−13073. | PubMed  | ISI | ChemPort |
  37. Uhlen, M. and Moks, T. 1990. Gene fusions for purpose of expression: an introduction. Methods in Enzymol. 185: 129−143. | Article | ChemPort |
  38. Brent, R. and Ptashne, M. 1981. Mechanism of action of the lex A gene product. Proc. Natl. Acad. Sci. USA 78: 4204−4208. | PubMed  | ChemPort |
  39. Sambrook, J., Fritsch, E.F. and Maniatis, T. 1989. Molecular Cloning, a Laboratory Manual, second edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  40. Norrander, J., Kempe, T. and Messing, J. 1983. Construction of improved M13 vectors using oligonucleotide-directed mutagenesis. Gene 26: 101−106. | Article | PubMed  | ISI | ChemPort |
  41. Shimatake, H. and Rosenberg, M. 1981. Purified lambda regulatory protein cII positively activates promoters for lysogenic development. Nature 292: 128−132. | PubMed  | ISI | ChemPort |
  42. Woods, S.A., Miles, J.S., Roberts, R.E. and Guest, J.R. 1986. Structural and functional relationships between fumarase and aspartase. Biochem. J. 237: 547−557. | PubMed  | ISI | ChemPort |
  43. Dorssers, L., Burger, H., Bot, F., Delwel, R., Geurts van Kessel, A., Lowen-berg, B. and Wagemaker, G. 1987. Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved non-coding sequence in mouse interleukin-3. Gene 55: 115−124. | Article | PubMed  | ISI | ChemPort |
  44. Zilberstein, A., Ruggieri, R., Korn, J.H. and Revel, M. 1986. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 5: 2529−2537. | PubMed  | ISI | ChemPort |
  45. Obaru, K., Fukuda, M., Maeda, S. and Shimada, K. 1986. A cDNA clone used to study mRNA inducible in human tonsil lar lymphocytes by a tumor promoter. J. Biochem. 99: 885−894. | PubMed  | ISI | ChemPort |
  46. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. and Wang, E.A. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528−1534. | PubMed  | ISI | ChemPort |
  47. Wong, G.G., Temple, P.A., Leary, A.C., Witek-Giannotti, J.S. et al. 1987 Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the urinary protein. Science 235: 1504−1508. | PubMed  | ISI | ChemPort |
  48. Kashima, N., Nishi-Takaoka, C., Fujita, T., Taki, S., Yamada, G., Hamuro, J. and Taniguchi, T. 1985. Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature 313: 402−404. | PubMed  | ISI | ChemPort |
  49. Lee, F., Yokota, T., Otsuka, T., Meyerson, P., Villaret, D., Coffman, R., Mosmann, T., Rennick, D., Roehm, N., Smith, C., Zlotnik, A. and Arai, K.-I. 1986. Isolation and characterization of a mouse interleukin cDNA clone that expressed B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 83: 2061−2065. | PubMed  | ChemPort |
  50. Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt-Lindqvist, S., Takahashi, M., Matsuda, F., Yaoita, Y., Takatsu, K. and Honjo, T. 1986. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324: 70−73. | PubMed  | ISI | ChemPort |
  51. Gearing, D.P., Gough, N.M., King, J.A., Hilton, D.J., Nicola, N.A., Simpson, R.J., Nice, E.C., Kelso, A. and Metcalf, D. 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 6: 3995−4002. | PubMed  | ISI | ChemPort |
  52. Anderson, D.M., Lyman, S.D., Baird, A., Wignall, J.M., Eisenman, J., Rauch, C., March, C.J., Boswell, H.S., Gimpel, S.D., Cosman, D. and Williams, D.E. 1990. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63: 235−243. | Article | PubMed  | ISI | ChemPort |
  53. Miller, J.H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  54. Micschendahl, M., Petri, T. and Hanggi, U. 1986. A novel prophage independent trp regulated lambda pL expression system. Bio/Technology 4: 802−808.
  55. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680−685. | PubMed  | ISI | ChemPort |
  56. Schagger, H. and von Jagow, G. 1987. Tricine-sodium dodecyl sulfate-poly-acrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100kDa. Anal. Biochem. 166: 368−379. | PubMed  | ISI | ChemPort |
  57. Avanzi, C.G., Brizzi, M.F., Giannotti, J., Ciarletta, A., Yang, Y.C., Pegoraro, L. and Clark, S.C. 1990. M-O7e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J. Cellular Physiol. 145: 458−464. | ISI |
  58. Thies, R.S., Bauduy, M., Ashton, B.A., Kurtzberg, L., Wozney, J.M. and Rosen, V. 1992. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318−1324. | Article | PubMed  | ISI | ChemPort |
  59. Warren, H.S., Hargreaves, J. and Happel, A.J. 1985. Some interleukin-3 dependent mast-cell lines also respond to interleukin-2. Lymphokine Res. 4: 195−204. | PubMed  | ISI | ChemPort |
  60. Pragnell, I.B., Wright, E.G., Lorimore, S.A., Adam, J., Rosendaal, M., De Lamarter, J.F., Freshney, M., Eckman, L., Sproul, A. and Wilkie, N. 1988. The effect of stem proliferation inhibitors demonstrated with an in vitro assay. Blood 72: 196−199. | PubMed  | ISI | ChemPort |
  61. Kitamura, T., Tange, T., Chiba, S., Kuwaki, T., Mitani, K., Urabe, A. and Takaku, F. 1989. Establishment and characterization of a unique human cell line that proliferates dependency on GM-CSF, IL-3 or erythropoietin. J. Cellular Physiol. 140: 323−334. | ISI | ChemPort |
  62. Kawasaki, E.S., Ladner, M.B., Wang, A.M., Van Arsdell, J., Warren, K., Coyne, M.Y., Schweickart, V.L., Lee, M-.T., Wilson, K.J., Boosman, A., Stanley, E.R., Ralph, P. and Mark, D.F. 1986. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-I). Science 230: 291−296. | ISI |
  63. Moreau, J.-F., Donaldson, D.D., Bennett, F., Witek-Giannotti, J., Clark, S.C. and Wong, G.G. 1988. Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336: 690−692. | Article | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1993 Nature Publishing Group | Privacy policy